Kyndryl (KD) Q2 2027 Earnings Call Transcript

Kyndryl reported Q2 fiscal 2027 revenue of $3.65 billion, down 1.9% year over year as reported, while adjusted EBITDA margin rose 190 basis points to 19.1% and adjusted pre-tax margin increased to 4.1%. First-half signings grew 34%, and management reaffirmed fiscal 2027 revenue guidance of flat to down 2% in constant currency, adjusted pre-tax income of $600 million-$700 million, and free cash flow of $400 million-$500 million, despite a $434 million first-half free-cash-flow use. Management expects $400 million-$500 million in annualized operating-expense savings by fiscal 2028 and said the company remains on track for its longer-term objectives.

Analysis

KD’s setup is improving operationally, but the market should distinguish margin repair from durable top-line acceleration. Workforce savings and delivery efficiencies can lift earnings as legacy contracts roll off; however, the company’s own outlook still implies revenue contraction, and the U.S. growth rate benefited from a one-off commercial resolution. Treat the margin trajectory as more credible than near-term organic growth until reported revenue confirms it.

The best leading indicator is profitable backlog conversion: signings and expected signing margins suggest better future mix, but long deal cycles, customer sovereignty reviews, and AI-provider uncertainty can defer start dates. The 25% signing gross margin is not recognized margin; execution, pricing concessions, and labor costs could erode the spread. The first-half cash use also makes the full-year cash target unusually dependent on a second-half working-capital reversal—watch receivables, payables, and renewal timing, not just EBITDA.

AI and sovereignty offerings may differentiate Kyndryl from large integrators such as Accenture and IBM, but announcements are not evidence of recurring software economics. The ServiceNow collaboration could improve KD’s service mix; its financial contribution is unquantified, so any read-through to NOW is premature. Broadcom’s VMware ecosystem may create modernization work, but the call establishes no material revenue linkage for AVGO.

Near term, the report supports cautious optimism, not a clean growth re-rating. Over 1–3 months, cash conversion and Consult growth are the key tests; over 6–18 months, savings and higher-value work matter only if they convert to recurring revenue and free cash flow.

Key Decisions for Investors

• KD: Consider a small, staged long rather than chasing an earnings-day move; add only if the next quarter shows Consult growth stabilizing and gross-margin improvement translating into operating cash. The thesis is falsified by a cut to FY27 free-cash-flow guidance or renewed deterioration in constant-currency revenue.
• Track second-half cash conversion as the primary catalyst: verify working-capital release against the seasonal explanation and the $400–$500 million annual FCF outlook. If cash remains materially negative after the expected reversal, reduce exposure even if adjusted EBITDA margins improve.
• Do not trade NOW or AVGO on partnership read-through alone. Reassess only after disclosed customer wins, commercial terms, or revenue contribution establish that the collaboration creates incremental economics rather than marketing reach.
• Treat European sovereignty and large-deal timing as a watch item: a concrete solution and resumed regional signings could shorten conversion delays; continued customer deferrals would undermine backlog quality. Avoid assigning value to announced AI capabilities before evidence of adoption and monetization.